2023-2025
Targeting early astrocyte dysfunction to block Alzheimer’s disease progression
Nicola J. Allen, PhD
The Salk Institute for Biological Studies
2020-2023
AMPylation-mediated chaperone regulation in Alzheimer’s disease
Matthias Truttmann, PhD
Medical School, University of Michigan
2018-2020
Structural plasticity of ApoE and its role in AD
Andrea Soranno, PhD
Washington University in St. Louis
2016-2018
Selective targeting of the corticothalamic network to improve cognition and behavior in Alzheimer’s disease
Jeannie Chin, PhD
Baylor College of Medicine
2014-2016
A novel Amyloid-Beta Receptor driving synapse loss in Alzheimer’s Disease
Carla J. Shatz, PhD
Stanford University
Preventing Progression of Alzheimer’s Disease
Bradley T. Hyman, MD, PhD
Harvard Medical School
2012-2014
Role of Metal Ions in Alzheimer’s Disease
Mi Hee Lim, PhD
University of Michigan
2010-2012
Propagation of Tau Protein Misfolding
Marc I. Diamond, MD
School of Medicine
Washington University
2008-2010
Blood Test for Alzheimer’s Disease: Measuring Amyloid Beta Production & Clearance Rates in Blood
Randall J. Bateman, MD
School of Medicine
Washington University
Neural Stem Cells and Inflammation:Implications for Alzheimer’s Disease
Brandi K. Ormerod, PhD
Department of Biomedical Engineering
University of Florida
2006-2008
NAD Hypothesis of Alzheimer’s Disease
Gang Yu, PhD
Center for Basic Neuroscience and
Department of Cell Biology
Southwestern Medical Center
University of Texas
2004-2006
Role of Macrophage Activation and Human Endogenous Retrovirus Expression in Alzheimer’s Disease
Michael S. McGrath, MD, PhD
Department of Medicine and Pathology
University of California, San Francisco
2002-2004
A Novel fMRI Method of the Detection of Incipient Alzheimer’s Disease
Allan L. Reiss, MD
Michael D. Greicius, MD, MPH
Department of Psychiatry and Behavioral Science
Stanford University
2000-2002
Hippocampal Vulnerability in Mouse Models of Alzheimer’s Disease
Sangram S. Sisodia, PhD
Department of Neurobiology, Pharmacology and Physiology
The University of Chicago
1998-2000
CNS-derived ApoE: Role in Lipid / Cholesterol Metabolism
David Holtzman, MD
School of Medicine
Department of Neurobiology and
Center for Study of Nervous System Injury
Washington University
1996-1998
Synaptotrophic Effects of ApoE
Eliezer Masliah, MD
School of Medicine
Departments of Neurosciences and of Pathology
University of California, San Diego
1994-1996
The Calcium-Dependant Crosslinking of Tau byTransglutaminase: A Possible Role in Neurofibrillary Tangle Formation
Gail V.W. Johnson, PhD
School of Medicine
Departments of Psychology and Behavioral Neurobiology
University of Alabama, Birmingham
1992-1994
Growth Factors in Alzheimer’s Disease
Fred H. Gage, PhD
Department of Neurosciences
University of California, San Diego
Neurodegeneration in Libyan Jews with Prion Protein Gene Mutations – Modeling The Disease In Transgenic Mice
Stanley B. Prusiner, MD
Department of Neurology
University of California, San Francisco
1990-1992
APOE and Alzheimer’s Disease
Allen Roses
Department of Medicine, Neurology
School of Medicine
Duke University
Molecular Pathology of Neuronal Degeneration in Alzheimer’s Disease
Dennis Selkoe
Harvard Medical School
Brigham and Women’s Hospital
